Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,767 papers from all fields of science
Search
Sign In
Create Free Account
brodimoprim
Known as:
2,4-diamino-5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (4)
Anti-Infective Agents
Enzyme Inhibitors
Folic Acid Antagonists
Trimethoprim
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study.
Nai-ning Song
,
Shaoyu Zhang
,
Quan-sheng Li
,
Changxiao Liu
Journal of Pharmaceutical and Biomedical Analysis
2008
Corpus ID: 24802453
2008
2008
Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping…
Shaoyu Zhang
,
Nai-ning Song
,
Quan-sheng Li
,
Hui-rong Fan
,
Changxiao Liu
Journal of chromatography. B, Analytical…
2008
Corpus ID: 5584105
2007
2007
Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim.
M. Caira
,
G. Bettinetti
,
M. Sorrenti
,
L. Catenacci
Journal of Pharmacy and Science
2007
Corpus ID: 43065161
The isolation and physicochemical characterization of four crystalline modifications of brodimoprim (5-[(4-bromo-3,5…
Expand
1999
1999
1H/15N HSQC NMR studies of ligand carboxylate group interactions with arginine residues in complexes of brodimoprim analogues and Lactobacillus casei dihydrofolate reductase.
W. D. Morgan
,
B. Birdsall
,
P. Nieto
,
A. Gargaro
,
J. Feeney
Biochemistry
1999
Corpus ID: 21467059
1H and 15N NMR studies have been undertaken on complexes of Lactobacillus casei dihydrofolate reductase (DHFR) formed with…
Expand
1995
1995
Solution structure of a brodimoprim analogue in its complex with Lactobacillus casei dihydrofolate reductase.
William D. Morgan
,
Berry Birdsall
,
V. Polshakov
,
Dasa Lipovsek Sali
,
Ivan Kompis
,
James Feeney
Biochemistry
1995
Corpus ID: 28865315
Two-dimensional (2D) double-quantum-filtered correlation spectroscopy (DQF-COSY), total correlation spectroscopy (TOCSY), nuclear…
Expand
Review
1993
Review
1993
Comparative antibacterial spectrum of trimethoprim and brodimoprim.
S. Amyes
Journal of chemotherapy
1993
Corpus ID: 21339843
Brodimoprim is a new 2,4-diaminobenzylpyrimidine that selectively inhibits bacterial and resistance plasmid dihydrofolate…
Expand
1993
1993
Brodimoprim in acute respiratory tract infections.
H. A. Salmi
Journal of chemotherapy
1993
Corpus ID: 31526363
Brodimoprim was studied in the treatment of acute respiratory tract infections in hospitalized, basically healthy, military…
Expand
1991
1991
Brodimoprim versus amoxicillin in the treatment of acute sinusitis.
R. Nyffenegger
,
D. Riebenfeld
,
A. Macciocchi
Clinical Therapeutics
1991
Corpus ID: 21364258
A new dihydrofolate inhibitor, brodimoprim, was compared with amoxicillin in the treatment of acute sinusitis in a general…
Expand
1984
1984
A 1H NMR study of the interactions and conformations of rationally designed brodimoprim analogues in complexes with Lactobacillus casei dihydrofolate reductase.
B. Birdsall
,
J. Feeney
,
+5 authors
A. Kroehn
Journal of Medicinal Chemistry
1984
Corpus ID: 2110157
A consideration of the detailed structural information available from X-ray crystallographic and NMR studies on complexes of…
Expand
1984
1984
Properties of brodimoprim as an inhibitor of dihydrofolate reductases.
R. Then
,
F. Hermann
Chemotherapy
1984
Corpus ID: 46852610
Based on both IC50 and Ki values, brodimoprim (BDP) was often found to be two- to threefold more effective than trimethoprim (TMP…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE